Eaton Corporation plc vs ImmunityBio Inc. Common Stock — how do they compare? Eaton Corporation plc trades at $429.15 (market cap $167.53B), while ImmunityBio Inc. Common Stock trades at $10 (market cap $10.33B). The key difference: Eaton Corporation plc is far larger — about 16.2× ImmunityBio Inc. Common Stock's market cap, and Eaton Corporation plc pays a 1.02% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eaton Corporation plc for 31 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| ETN | IBRX | |
|---|---|---|
Market Cap | $167.53B | $10.33B |
Volume | 1,729,194 | 11,745,198 |
Sector | Industrials | Health |
52-Week High | $459.96 | $11.55 |
52-Week Low | $315.82 | $1.98 |
Typical Hold Time | 31 Days | 0 Days |
Enterprise Value | $188.16B | $10.79B |
Dividend Yield | 1.02% | — |
Signals from Pluang's Aura AI — not financial advice
Eaton Corporation (ETN) trades at $431.33, down 3.09% today but maintains strong analyst support with 28 buy ratings and a $502.38 consensus price target. The company demonstrates consistent earnings beats in recent quarters and benefits from strategic acquisitions in data center and aerospace markets. Technical indicators show a bullish moving average trend with neutral oscillators, while fundamentals reveal solid profitability with 12.75% net income margin and 19.71% ROE.
ETN presents a compelling investment case driven by AI data center demand and grid modernization trends, though elevated valuation multiples (P/E 43.92) warrant monitoring. Key risks include execution of recent acquisitions and competitive pressures in the electrical equipment sector. The stock offers 16% upside to consensus targets with strong institutional conviction supporting long-term growth prospects.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →